此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Women's HIV SeroIncidence Study (ISIS)

2022年8月25日 更新者:HIV Prevention Trials Network
Approximately 30 percent of new HIV infections in the Unites States occur in women, with a disproportionate number occurring in women of color. This observational study has been designed to help determine the HIV incidence among women in the study communities as well as to identify steps that women can take to lower their HIV-infection risk.

研究概览

地位

完全的

详细说明

In 1985 women accounted for only 8 percent of new AIDS diagnoses in the United States. Today women are estimated to account for nearly 30 percent of the people who are diagnosed with new HIV infections (incidence). A disproportionate amount of those infections (80 percent) occur among Black and Hispanic girls and women. This observational study has been designed to help determine the HIV incidence among women in the study communities as well as to identify steps that women can take to lower their HIV-infection risk.

Research teams will conduct eligibility screening interviews with women whom they have encountered in various locations within the study communities. Eligibility screenings, as well as subsequent study visits, will take place in a variety of mutually agreeable locations that are capable of providing both privacy and confidentiality. Examples include clinics, mobile vans, community organizations or other appropriate public places. The eligibility interview contains topics related to sexual behavior, drug and alcohol use, incarceration history and previous STI diagnosis and treatment. Information about where the potential participant resides and her current sexual partners will also be gathered.

The women who are found to be eligible will be asked to provide a blood sample for HIV and other investigational testing. They will also be asked to participate in a longer interview. All participants will receive HIV risk-reduction counseling, free condoms and appropriate referrals. Monthly contact will be maintained with participants through information that was provided upon enrollment. A phone number that participants can use to contact the research team will also be provided. Monthly calls will each last about 5 to 15 minutes.

About six months after enrolling each participant will be scheduled to have another in-person visit with study staff to complete an interview similar to the eligibility interview. Women who have tested HIV negative will be asked to provide another blood sample for HIV testing during that same period of time, while women who are living with HIV will be asked to provide blood samples to evaluate their HIV-related health. Women who enroll during the earliest portion of the study may be asked to complete a second visit in another six months. Those women will continue to receive monthly contacts between the dates of their first and second visits.

In addition to the primary participant group, a small group of women from four of the study communities will also be recruited to participate in interviews and focus groups that will cover issues similar to the topics included in the eligibly screening. A small group of men from those same four study communities will also be recruited to participate in similar focus groups.

研究类型

观察性的

注册 (实际的)

2099

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • District of Columbia
      • Washington、District of Columbia、美国、20037
        • George Washington University
    • Georgia
      • Atlanta、Georgia、美国、30308
        • The Ponce de Leon Center
      • Decatur、Georgia、美国、30030
        • Hope Clinic of The Emory Vaccine Center
    • Maryland
      • Baltimore、Maryland、美国、21287
        • Johns Hopkins Adult AIDS CRS
    • New Jersey
      • Newark、New Jersey、美国、07103
        • New Jersey Medical School- Adult Clinical Research Ctr. CRS
    • New York
      • Bronx、New York、美国、10452
        • Bronx- Lebanon Hospital Center Clinical Research Site
      • New York、New York、美国、10027
        • Harlem Prevention Ctr. CRS
    • North Carolina
      • Chapel Hill、North Carolina、美国、27514
        • Unc Aids Crs
      • Raleigh、North Carolina、美国、27630
        • Wake County Health and Human Services

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

概率样本

研究人群

Men and women residing in areas from defined geographic areas with high HIV prevalence and poverty

描述

HPTN 064, potential participants will be approached at randomly selected locations within study communities. As a result, potential participants are not able to self-refer directly through phone, email or in-person.

Inclusion Criteria for Women:

  • Self identify as a woman
  • 18 to 44 years of age, inclusive on the date of screening
  • Willing to receive HIV test results
  • Resides in a designated study community
  • Has engaged in unprotected (e.g. without a condom) vaginal and/or anal sex with a man during the prior 6 months
  • At least one of the following criteria:

    • Illicit injected and/or noninjected drug use (e.g. heroin, cocaine, crack cocaine, methamphetamine, and/or prescription drugs used outside the oversight of a medical professional) within 6 months. Participants whose only illicit drug use is marijuana do not meet the illicit drug use eligibility criteria.
    • Alcohol dependence (within 6 months)
    • Binge drinking defined as four or more drinks at one time (e.g. during the morning, afternoon or evening) within 6 months
    • Incarceration within 5 years (jail and/or prison)
    • STI (gonorrhea, Chlamydia, trichomonas, or syphilis) within 6 months
    • Exchange of sex for commodities (e.g. drugs, money, shelter) within 6 months
    • Male sexual partner within 6 months with any history of self-reported use of illicit injected or noninjected drugs within 6 months, incarceration (within 5 years), STIs (within 6 months), HIV-infected diagnosis, or history of binge drinking defined as 5 or more drinks at one time (within 6 months) and/or alcohol dependence (within 6 months)

Inclusion Criteria for Men:

  • Self identify as a man
  • 18 years of age or older
  • Resides in a designated community
  • Unprotected vaginal and/or anal sex with a woman during the prior 6 months
  • At least one of the following criteria:

    • Illicit injected and/or noninjected drug use within 6 months
    • Alcohol dependence (within 6 months)
    • Binge drinking defined as five or more drinks at one time (e.g. during the morning, afternoon or evening) within 6 months
    • Incarceration (within 5 years, including jail and/or prison)
    • STI within 6 months
    • Exchange of sex for commodities
    • HIV-infected

Exclusion Criteria for Women:

  • History of prior HIV-infected diagnosis
  • Planning on moving out of state within the study follow-up period or traveling out of state for more than 2 consecutive months during the study follow-up period
  • Current enrollment in an HIV prevention trial
  • Current or past participation in an HIV vaccine trial
  • Any condition that, in the opinion of the study staff, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

Exclusion Criteria for Men:

  • Any condition that, in the opinion of the study staff, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
1
Women residing in areas from defined geographic areas with high HIV prevalence and poverty
2
Men residing in areas from defined geographic areas with high HIV prevalence and poverty

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Estimation of the overall HIV-1 incidence rate among 2,000 women in the US from defined geographic areas with high HIV prevalence and poverty
大体时间:Throughout study
Throughout study

次要结果测量

结果测量
大体时间
Evaluation of laboratory assays for HIV-1 incidence determination
大体时间:Throughout study
Throughout study
Estimation of recruitment and retention rates
大体时间:Throughout study
Throughout study
Assessment of women's preferred recruitment and retention strategies for future studies
大体时间:Throughout study
Throughout study
Description of social, structural, and contextual factors in a subgroup of female participants to inform future intervention studies
大体时间:Throughout study
Throughout study
Estimation of HIV-1 prevalence rate among women who have not reported previously testing HIV positive
大体时间:Throughout study
Throughout study
Exploration of facilitators and barriers to HIV testing among men residing in high risk areas to inform future studies
大体时间:Throughout study
Throughout study

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Sally Hodder, MD、UMDNJ - New Jersey Medical School
  • 学习椅:Jessica Justman、Columbia University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2009年4月1日

初级完成 (实际的)

2011年3月1日

研究完成 (实际的)

2011年3月1日

研究注册日期

首次提交

2009年10月14日

首先提交符合 QC 标准的

2009年10月14日

首次发布 (估计)

2009年10月15日

研究记录更新

最后更新发布 (实际的)

2022年8月30日

上次提交的符合 QC 标准的更新

2022年8月25日

最后验证

2022年8月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

IPD 计划说明

Data was collated into manuscripts by the statistical and data management center for the HPTN.

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

艾滋病毒感染的临床试验

3
订阅